UBS’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$17.6M Buy
1,311,935
+313,606
+31% +$4.75M 0.01% 1041
2014
Q2
$16M Buy
998,329
+900,554
+921% +$14M 0.01% 1014
2014
Q1
$1.76M Buy
97,775
+9,823
+11% +$170K ﹤0.01% 2906
2013
Q4
$1.36M Sell
87,952
-1,989
-2% -$29.3K ﹤0.01% 3208
2013
Q3
$1.34M Sell
89,941
-130,252
-59% -$1.96M ﹤0.01% 3013
2013
Q2
$2.85M Buy
+220,193
New +$2.95M ﹤0.01% 2160

Other funds holding MDRX

UBS's MDRX Position: Q3 2014 in Review

UBS increased its Veradigm Inc. Common Stock (MDRX) stake by 31% in Q3 2014, buying an estimated $4.75M and bringing the position to 1,311,935 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1041.

UBS first reported a position in MDRX in Q2 2013 and has held it in 6 quarters since. 225 funds tracked by Wall St. Rank hold MDRX as of Q3 2014.

  • UBS held 1,311,935 shares of Veradigm Inc. Common Stock worth $17.6M as of Q3 2014.
  • UBS bought 313,606 Veradigm Inc. Common Stock shares in Q3 2014, an estimated $4.75M.
  • Veradigm Inc. Common Stock made up 0.01% of UBS's portfolio in Q3 2014, its #1041 holding.
  • UBS first reported a position in Veradigm Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.